{{Rsnum
|rsid=4702484
|Gene=ADCY2
|Chromosome=5
|position=7649747
|Orientation=plus
|GMAF=0.1492
|Gene_s=ADCY2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 18.6 | 2.7
| HCB | 67.6 | 30.1 | 2.2
| JPT | 63.7 | 33.6 | 2.7
| YRI | 100.0 | 0.0 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 67.6 | 30.1 | 2.2
| CHD | 62.4 | 34.9 | 2.8
| GIH | 68.3 | 27.7 | 4.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 51.7 | 44.8 | 3.4
| MKK | 85.9 | 14.1 | 0.0
| TSI | 76.5 | 22.5 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=6E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}